Search Results

SP-13786 25 mg  | ≥95%

Cayman Chemical

An inhibitor of FAP

More Information Supplier Page

×

SP-13786

SP-13786 100 mg  | ≥95%

Cayman Chemical

An inhibitor of FAP

More Information Supplier Page

×

SP-13786

SP-13786 10 mg  | ≥95%

Cayman Chemical

An inhibitor of FAP

More Information Supplier Page

×

SP-13786

BT-11 50 mg  | ≥98%

Cayman Chemical

A LANCL2 pathway activator

More Information Supplier Page

×

BT-11

BT-11 5 mg  | ≥98%

Cayman Chemical

A LANCL2 pathway activator

More Information Supplier Page

×

BT-11

BT-11 25 mg  | ≥98%

Cayman Chemical

A LANCL2 pathway activator

More Information Supplier Page

×

BT-11

BT-11 10 mg  | ≥98%

Cayman Chemical

A LANCL2 pathway activator

More Information Supplier Page

×

BT-11

JNJ-42847922 50 mg  | ≥98%

Cayman Chemical

An orexin receptor 2 antagonist

More Information Supplier Page

×

JNJ-42847922

JNJ-42847922 5 mg  | ≥98%

Cayman Chemical

An orexin receptor 2 antagonist

More Information Supplier Page

×

JNJ-42847922

JNJ-42847922 25 mg  | ≥98%

Cayman Chemical

An orexin receptor 2 antagonist

More Information Supplier Page

×

JNJ-42847922